Jefferies Group LLC Galapagos Nv Transaction History

Jefferies Group LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 13, 2020	SELL	$122.47 - $213.56 $249,716 - $435,448	-2,039 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$185.52 - $231.25 $324,474 - $404,456	1,749 Added 603.1%	2,039 $402,000
Q1 2020 May 15, 2020	SELL	$143.0 - $274.03 $506,220 - $970,066	-3,540 Reduced 92.43%	290 $57,000
Q4 2019 Feb 13, 2020	BUY	$146.12 - $215.82 $559,639 - $826,590	3,830 New	3,830 $792,000
Q2 2019 Aug 14, 2019	SELL	$111.45 - $128.93 $2,563 - $2,965	-23 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$89.61 - $117.78 $2,061 - $2,708	23 New	23 $3,000
Q4 2018 Feb 14, 2019	SELL	$87.81 - $110.65 $319,628 - $402,766	-3,640 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$90.63 - $120.22 $329,893 - $437,600	3,640 New	3,640 $409,000
Q1 2018 May 15, 2018	SELL	$94.51 - $120.23 $1.02 Million - $1.29 Million	-10,745 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$84.48 - $104.02 $907,737 - $1.12 Million	10,745	10,745 $1.01 Million

12.3M

69.1K

42.7K

Ticker GLPG
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,835,500
Market Cap $1.76B
Description
Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

Stay updated on Jefferies Group LLC with notifications on news.